Rl. Brown et al., SERUM-FREE CULTURE CONDITIONS FOR CELLS CAPABLE OF PRODUCING LONG-TERM SURVIVAL IN LETHALLY IRRADIATED MICE, Stem cells, 15(3), 1997, pp. 237-245
The goal of ex vivo culture is to expand and/or differentiate cells in
culture such that they retain their functional characteristics when r
einfused into a patient. The studies presented here analyzed the use o
f culture conditions devoid of serum to expand murine hematopoietic st
em cells. Bone marrow cells from male B6D2F1/J mice were cultured for
up to 28 days in serum-free medium in the absence or presence of stem
cell factor (SCF), GM-CSF or a combination of the two factors. Cells c
ultured for up to 21 days were assessed for granulocyte-macrophage col
ony-forming cells (GM-CFC), spleen colony-forming units, and cells res
ponsible for short-term and long-term hematopoietic repopulation in le
thally irradiated mice. Compared to initial seeding levels, the presen
ce of SCF and GM-CSF increased total cell numbers 90-fold and GM-CFC n
umbers 42-fold over a 21-28 day culture period. Although spleen colony
-forming unit cells did not increase, they were maintained at initial
seeding levels over a 21-day period in the presence of SCF and GM-CSF.
In lethally irradiated mice, survival enhancement and hematologic rec
onstitution were optimum with cells cultured for only seven days: surv
ival at six months was 100% with cells cultured in SCF plus GM-CSF or
SCF alone, compared to 50% with cells cultured with only GM-CSF. Hybri
dization analysis of bone marrow, spleen and thymus DNA from irradiate
d mice transplanted with these cultured cells confirmed male donor cel
l-derived repopulation at 45 days and 180 days post-transplant. These
studies illustrate that murine GM-CFM can be expanded and that long-te
rm repopulating hematopoietic cells can, at the minimum, be maintained
ex vivo in serum-free culture. The use of defined serum-free culture
systems holds great promise for further evaluation of the mechanisms t
hat control hematopoietic stem cell proliferation.